Drug Discovery & Development News: Bipartisan Effort Demands DEA Action on Marijuana Scheduling & more...

Thu, 25 Apr 2024 20:28:12 -0700

Please click here to view this in your browser.

Bipartisan Effort Demands DEA Action on Marijuana Scheduling

Marijuana is currently classified as a Schedule I drug, meaning these are “drugs with no currently accepted medical use and a high potential for abuse.” However, a team of 21 bipartisan congressional leaders from both the Senate and House of Representatives hopes to change that as they recently sent a ...

Game-Changing New Receptor Unlocks the Potential of CAR-T Cell Therapy

Exciting cancer therapy innovations were announced in Cell Reports Medicine in the realm CAR-T-cell therapy (chimeric antigen receptor T cell). By designing a new cytokine receptor, Yoshikawa et al. of Keio University in Tokyo have elevate the efficacy and ...

Cryoablation Presents a New Avenue for Breast Cancer Treatment

Cryoablation (also called cryosurgery or cryotherapy) uses very low temperatures to freeze abnormal tissue, destroying it during freezing. A medical professional uses a cryoprobe, which is cooled with liquid nitrogen or compressed argon and pressed against the treatment area. Cryoablation does not require a ...

How a Common Antibiotic Ointment Could Help Fight Viruses

Antibiotics are used to fight bacterial infections, and unless there is a risk that a viral infection will lead to more problems, antibiotics are not often recommended for other illnesses. However, a new study has suggestd that a general antibiotic called neomycin could help prevent viral infections in the ...

Study Reveals Significant Medical Cannabis Enrollment Increases

A recent federal study found a significant increase in enrollment in state-legal medical cannabis programs across the United States. Researchers from the Centers for Disease Control and Prevention (CDC), the Department of Veterans Affairs (VA), and the University of Michigan published the findings in the Annals of ...

UPCOMING WEBINARS

Advancing cancer organoid drug screening with novel media systems

Dr. Christophe Deben, Ph.D. Oncology and Cancer Biology - Professor Tumor Biology and Organoids, University of Antwerp

Dr. Colin Paul - Cell Biology R&D Staff Scientist, Thermo Fisher Scientific.

Explore the latest developments in cancer organoid (tumoroid) technology and the promising implications for drug screening during this two-part webinar. In the first half, Colin Paul will discuss the capabilities of OncoPro medium, a novel system that simplifies the use of tumoroids for drug screening applications. This session will review potential areas of optimization and highlight how OncoPro ...

MAY 08, 2024 7:00 AM PDT

Overcoming Challenges with AAA Aggregate Analysis Using a Novel SEC Column to Determine Critical Quality Attributes

Shilin Cheung, Ph.D. - Sr. Research Scientist, Phenomenex Inc

As the most widely used viral vector for gene therapies, Adeno-Associated Viruses (AAVs) present unique advantages, including their ability to enter both dividing and non-dividing cells, the absence of human viral illness, and minimal immune response triggers. However, the complexity and size of AAVs pose challenges for their analysis. Traditional approaches struggle with their larger ...

MAY 08, 2024 8:00 AM PDT

Innovative Storage Techniques for Lyophilized Laboratory Samples

Zachary Zakibe - Product Manager
Labconco

Jeff Madden - Vertical Marketing Manager
Labconco

Lyophilization, or freeze drying, is a common laboratory technique used in a wide range of applications. Tissues, vaccines, food, chemical compounds, circuit boards, artifacts and more can all be preserved using this technique. However, the ultimate question remains, "How do we keep our samples safe once they are lyophilized?" Proper sample storage is equally as important as proper ...

MAY 08, 2024 10:00 AM PDT

See More Webinars

SCIENTIFIC PRODUCTS

LEICA BIOSYSTEMS

Aperio CS2

MAXCYTE

ExPERT STx™ Scalable static or flow electroporation

CREATIVE BIOLABS

Mouse Anti-gp41 (HIV-1) Recombinant Antibody...

INFORS HT

Multifors 2 Bench-Top Bioreactor

BMG LABTECH